Remembering Jane Cooke Wright, a Black woman physician, who was among seven founders of ASCO

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sometime in 1995, Edith Mitchell, a U.S. Air Force oncologist who at the time served as commander of the 131st Medical Squadron at Lambert-St. Louis International Airport, first heard the name Jane Cooke Wright.

Karen Antman, then president of the American Society of Clinical Oncology, wanted to know whether Mitchell, who is Black, has heard that a Black woman oncologist was among ASCO’s seven founding members.

Mitchell had no idea.

Antman reached out to Wright, inviting her to the 1995 ASCO annual meeting. Mitchell, too, reached out to Wright. This started a friendship with Wright and her family members.

Wright died on Feb. 19, 2013, at age 93.

A photo archive chronicling Wright’s life is posted here.

The text of a eulogy by Mitchell, now a professor and associate director for diversity services at Thomas Jefferson University Sidney Kimmel Cancer Center, delivered on behalf of the National Medical Association at a memorial service for Wright is published on the Cancer History Project.

Edith P. Mitchell
Clinical professor, medicine and medical oncology, Department of Medical Oncology, director, Center to Eliminate Cancer Disparities, associate director, diversity affairs, Sidney Kimmel Cancer Center at Jefferson; 116th president of the National Medical Association
Table of Contents

YOU MAY BE INTERESTED IN

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 
Edith P. Mitchell
Clinical professor, medicine and medical oncology, Department of Medical Oncology, director, Center to Eliminate Cancer Disparities, associate director, diversity affairs, Sidney Kimmel Cancer Center at Jefferson; 116th president of the National Medical Association

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login